18889881171
Kalkine 0
countryflagUS

Bionovate Technologies Corp

Healthcare US BIIO

0.0001USD
-(-%)

Last update at 2024-06-26T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00077M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Income before tax -0.10654M -0.12205M -0.20890M -1.74074M -0.34108M
Minority interest - - - 0.00000M 0.00000M
Net income -0.10654M -0.12205M -0.20890M -1.74074M -0.32331M
Selling general administrative 0.05M 0.03M 0.06M 0.12M 0.09M
Selling and marketing expenses - - - - -
Gross profit - - - 0.00000M 0.00091M
Reconciled depreciation - - - - -
Ebit -0.04537M -0.03306M -0.05654M -0.11888M -0.08773M
Ebitda -0.04561M -0.03295M -0.05683M -1.67330M -0.28047M
Depreciation and amortization - - - - -
Non operating income net other - - - 0.00000M 0.00000M
Operating income -0.04537M -0.03306M -0.05654M -0.11888M -0.08773M
Other operating expenses - - - 0.00000M 0.00000M
Interest expense 0.06M 0.09M 0.15M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.06094M -0.08909M -0.15206M -0.06743M -0.06061M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense - - - 0.00000M 0.00000M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00539M
Total operating expenses 0.05M 0.03M 0.06M 0.12M 0.09M
Cost of revenue - - - 0.00000M 0.00448M
Total other income expense net -0.00024M 0.00010M -0.00029M -1.55443M -0.19274M
Discontinued operations - - - 0.00000M 0.02M
Net income from continuing ops -0.10654M -0.12205M -0.20890M -1.74074M -0.34108M
Net income applicable to common shares -0.10654M -0.12205M -0.20890M -1.74074M -0.32331M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Total assets 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Intangible assets - - - 0.00000M 0.00000M
Earning assets - - - - -
Other current assets - - - 0.00000M 0.00000M
Total liab 0.50M 0.40M 0.33M 0.31M 0.23M
Total stockholder equity -0.50321M -0.39666M -0.33229M -0.30968M -0.22915M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 0.05M - 0.04M 0.19M 0.15M
Common stock 0.00077M 0.00594M 0.00002M 0.00156M 0.00003M
Capital stock 0.00077M 0.00594M 0.00156M - -
Retained earnings -2.80478M -2.69824M -2.57619M -2.36730M -0.62656M
Other liab - - - 0.00000M 0.00000M
Good will - - - 0.00000M 0.00000M
Other assets - - - 0.00000M 0.00000M
Cash 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Cash and equivalents - - - - -
Total current liabilities 0.50M 0.40M 0.33M 0.31M 0.23M
Current deferred revenue - - - - -
Net debt 0.24M 0.19M 0.22M 0.27M -
Short term debt - - 0.18M 0.00000M 0.00000M
Short long term debt 0.24M 0.19M 0.22M 0.27M 0.19M
Short long term debt total - - - - -
Other stockholder equity - - - 0.00000M 0.01M
Property plant equipment - - - 0.00000M 0.00000M
Total current assets 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Long term investments - - - 0.00000M 0.00000M
Net tangible assets -0.50321M -0.39666M -0.33229M -0.30968M -0.22915M
Short term investments - - - 0.00000M 0.00000M
Net receivables - - - - -
Long term debt - - - 0.00000M 0.00000M
Inventory - - - 0.00000M 0.00000M
Accounts payable 0.03M 0.03M 0.02M 0.04M 0.04M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income - - - 0.00000M 0.00000M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - - - 0.00000M 0.00000M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other - - 0.00000M 0.00000M 0.00000M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Capital lease obligations - - - 0.00000M 0.00000M
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Type yearly yearly yearly yearly yearly
Date 2021-06-30 2020-06-30 2019-06-30 2018-06-30 2017-06-30
Investments - - - 0.00000M 0.00706M
Change to liabilities 0.05M 0.07M 0.07M 0.04M 0.01M
Total cashflows from investing activities - - - 0.00000M 0.00706M
Net borrowings - - - 0.00000M 0.00559M
Total cash from financing activities - - - 0.00000M -0.01759M
Change to operating activities - - - 0.07M 0.07M
Net income -0.10654M -0.12205M -0.20890M -1.74074M -0.32331M
Change in cash 0.00000M 0.00000M 0.00000M 0.00000M -0.00094M
Begin period cash flow 0.00000M 0.00000M 0.00000M 0.00000M 0.00094M
End period cash flow 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total cash from operating activities 0.00000M 0.00000M 0.00000M 0.00000M 0.01M
Issuance of capital stock - - - - -
Depreciation - - - 0.00000M 0.00000M
Other cashflows from investing activities - - - 0.00000M 0.00472M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory - - - 0.00000M 0.00000M
Change to account receivables - - - 0.00000M 0.00000M
Sale purchase of stock - - - 0.00000M -0.02318M
Other cashflows from financing activities - - - 0.00000M 0.00000M
Change to netincome 0.05M 0.03M 0.04M 1.58M 0.20M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital 0.05M 0.07M 0.07M 0.11M 0.08M
Stock based compensation - - - - -
Other non cash items 0.05M 0.05M 0.14M 0.08M 0.06M
Free cash flow 0.00000M 0.00000M 0.00000M 0.00000M 0.01M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
BIIO
Bionovate Technologies Corp		 - -% 0.0001 - - - - -4.9375
ABT
Abbott Laboratories		 -1.34 1.01% 131.71 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -2.5 0.66% 377.25 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -3.18 3.77% 81.23 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.4 0.38% 104.24 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.

Bionovate Technologies Corp

Gewerbestrasse 10, Cham, Switzerland, 6330

Key Executives

Name Title Year Born
Mr. Timothy Jones Pres, CEO, CFO, Sec., Treasurer & Director 1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.